AIM
MNTA

Acrospire Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Acrospire Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,067
Closed -$18K – 1783
2017
Q2 		$18K Sell
1,067
-1,000
-48% -$15.2K 0.02% 1597
2017
Q1 		$28K Sell
2,067
-3,036
-59% -$47.6K 0.02% 1412
2016
Q4 		$77K Buy
5,103
+3,192
+167% +$42.2K 0.03% 1108
2016
Q3 		$22K Sell
1,911
-500
-21% -$5.88K 0.01% 1475
2016
Q2 		$26K Buy
+2,411
New +$24.9K 0.02% 1441

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Acrospire Investment Management's MNTA Position: Q3 2017 in Review

Acrospire Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2017, closing a stake of 1,067 shares — an estimated $18K sold.

Acrospire Investment Management first reported a position in MNTA in Q2 2016 and held it in 5 quarters. The position peaked at $77K in Q4 2016. 158 funds tracked by Wall St. Rank hold MNTA as of Q3 2017.

  • Acrospire Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,067 Momenta Pharmaceuticals, Inc. shares in Q3 2017, an estimated $18K.
  • Acrospire Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $77K in Q4 2016.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.